Skip to main content

Apert Syndrome

  • Chapter
  • First Online:
Acneiform Eruptions in Dermatology

Abstract

Apert syndrome is a condition characterized by skeletal abnormalities as well as acne. It was first described in two cases by Wheaton in 1894 [1, 2] and by renowned French pediatrician Eugène Charles Apert, who in 1906 reported several individuals with congenital malformations of the skull and syndactyly of the hands and feet [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV. Syndromic craniosynostosis: from history to hydrogen bonds. Orthod Craniofac Res. 2007;10(2):67–81.

    Article  PubMed  Google Scholar 

  2. Wheaton SW. Two specimens of congenital cranial deformity in infants associated with fusion of the fingers and toes. Trans Pathol Soc Lond. 1894;45:238.

    Google Scholar 

  3. Steffen C. The man behind the eponym. Eugene Apert (1868–1940). Am J Dermatopathol. 1984;6:223–4.

    Article  PubMed  CAS  Google Scholar 

  4. Boulet SL, Rasmussen SA, Honein MA. A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A. 2008;146A:984–91.

    Article  PubMed  Google Scholar 

  5. Blank CE. Apert’s syndrome (a type of acrocephalosyndactyly)—observations on British series of 39 cases. Ann Hum Genet. 1950;24:151–63.

    Article  Google Scholar 

  6. Melnik BC. Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinol. 2009;1(3):141–56.

    Article  PubMed  CAS  Google Scholar 

  7. Melnik BC. FoxO1- the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges. 2010;8:105–14.

    PubMed  Google Scholar 

  8. Melnik BC. Is nuclear deficiency of FoxO1 due to increased growth factor⁄PI3K⁄Akt-signalling in acne vulgaris reversed by isotretinoin treatment? Br J Dermatol. 2010;162:1398–400.

    Article  PubMed  CAS  Google Scholar 

  9. Wilkie AO, Slaney SF, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995;9:165–72.

    Article  PubMed  CAS  Google Scholar 

  10. Melnik BC, Schmitz G, Zouboulis CC. Anti-acne agents attenuate FGFR2 signal transduction in acne. J Investig Dermatol. 2009;129:1868–77.

    Article  PubMed  CAS  Google Scholar 

  11. Chen W, Obermayer-Pietsch B, Hong JB, et al. Acne-associated syndromes; models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol. 2011;25:637–46.

    Article  PubMed  CAS  Google Scholar 

  12. Henderson CA, Knaggs H, Clark A, Highet AS, Cunliffe WJ. Apert’s syndrome and androgen receptor staining of the basal cells of sebaceous glands. Br J Dermatol. 1995;132:139–43.

    Article  PubMed  CAS  Google Scholar 

  13. Freiman A, Tessler O, Barankin B. Apert syndrome. Int J Dermatol. 2006;45:1341–3.

    Article  PubMed  Google Scholar 

  14. Cohen MM, Kreiborg S. Cutaneous manifestations of Apert syndrome. Am J Med Genet. 1995;58:94–6.

    Article  PubMed  Google Scholar 

  15. Cohen Jr MM, Kreiborg S. Visceral anomalies in the Apert syndrome. Am J Med Genet. 1993;45:758–60.

    Article  PubMed  Google Scholar 

  16. Solomon LM, Fretzin D, Pruzansky S. Pilosebaceous abnormalities in Apert’s syndrome. Arch Dermatol. 1970;102:381–5.

    Article  PubMed  CAS  Google Scholar 

  17. Atherton DJ, Rebello T, Wells RS. Apert’s syndrome with severe acne vulgaris. Proc Roy Soc Med. 1976;69:517–8.

    PubMed  CAS  Google Scholar 

  18. Downs AMR, Condon CA, Tan R. Isotretinoin therapy for antibiotic-refractory acne in Apert’s syndrome. Clin Exp Dermatol. 1999;24:461–3.

    Article  PubMed  CAS  Google Scholar 

  19. Robinson D, Wilms NA. Successful treatment of the acne of Apert syndrome with isotretinoin. J Am Acad Dermatol. 1989;21:315–6.

    Article  Google Scholar 

  20. Campanati A, Marconi B, Penna L, Paolinelli M, Offidani A. Pronounced and early acne in Apert’s syndrome: a case successfully treated with oral isotretinoin. Eur J Dermatol. 2002; 12:496–8.

    PubMed  Google Scholar 

  21. Gilaberte M, Puig L, Alomar A. Isotretinoin treatment of acne in a patient with Apert syndrome. Pediatr Dermatol. 2003;20:443–6.

    Article  PubMed  Google Scholar 

  22. Parker TL, Roth JG, Esterly NB. Isotretinoin for acne in Apert syndrome. Pediatr Dermatol. 1992;9:298–300.

    Article  PubMed  CAS  Google Scholar 

  23. Hsieh T, Ho N. Resolution of acne following therapy with an oral contraceptive in a patient with Apert syndrome. J Am Dermatol. 2005;53(1):173–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Albahrani, Y., Zeichner, J.A. (2014). Apert Syndrome. In: Zeichner, J. (eds) Acneiform Eruptions in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8344-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8344-1_25

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8343-4

  • Online ISBN: 978-1-4614-8344-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics